Sign in Create account

Gujarat Themis Biosyn Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: GUJTHEM BSE: 506879
₹387.60
▼ -18.90 (-4.65%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
78/100
Strong
Valuation
—/100
Expensive
Momentum
31/100
Neutral

QVM read Quality business Quality Strong, Valuation Expensive, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹4,223 Cr
PE (TTM)
86.7
Industry median 36.1 (152 companies)
Price to Book
14.7
PEG (TTM)
-16.4
Institutions holding %
2.95%
FII + DII, latest filed period
Piotroski Score
4
Relative return vs Nifty50, qtr %
3.6
Relative return vs Sector, qtr %
-2.1
Free Cash Flow
₹-124 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
22.89%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
2.30%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
18.07%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
35.01%
as of Sept. 30, 2025
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
22.07%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
1.12
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.56
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
14.88
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
33.69%
as of Sept. 30, 2025
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
38.71%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
40.19%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
9.12%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
15.33%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
15.95%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

3 of 7 met
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • Yes Quality score is Strong (70 or more)
  • No Piotroski F-score is 7 or more (score 4)
  • No Debt to equity is below 0.5 (0.56)
  • Yes Return on equity is 15% or more (15.9%)
  • No Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

1 of 3 met
  • No FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • No Promoter pledge is 5% of their holding or less and not rising (5.4% pledged)

Peer comparison

2 of 3 met
  • No 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

0 of 6 met
  • No Price sits in the Buy zone of its own historical PE range (Sell Zone)
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-4.6%
Low 386.5000 · High 408.6000
1W return
-5.6%
Low 386.5000 · High 423.9000
1M return
-8.2%
Low 386.5000 · High 470.0500
52W return
-3.4%
Low 225.0500 · High 479.0000
Lifetime High ₹469.9000 (Oct. 27, 2025)
Lifetime Low ₹218.9100 (Feb. 28, 2025)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish2
Bearish4
5D
401.3
10D
407.6
20D
409.5
50D
398.9
100D
385.8
200D
362.2

Delivery and volume

Day avg. delivery
47.3%
Week avg. delivery
50.6%
Month avg. delivery
57.3%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

394.23
Pivot
First resistance401.97
Second resistance416.33
Third resistance424.07
First support379.87
Second support372.13
Third support357.77
Day RSI42.2
Day MFI46.2
Day MACD1.03
Day MACD signal6.20

Beta

1M0.34
3M0.39
1Y1.62
3Y1.81

Price change analysis

↓ -8.2%
Over 1 Month
LowHigh
386.50470.05
↓ -2.1%
Over 3 Months
LowHigh
341.65470.05
↑ 56.9%
Over 6 Months
LowHigh
235.50470.05
↓ -3.4%
Over 1 Year
LowHigh
225.05479.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 86.7 (own history: 46.4–100.8)
Sell Zone

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹44 Cr
Net profit (June 30, 2026)
₹11 Cr
Basic EPS (June 30, 2026)
₹1.0200

Ranks #64 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter70.86%
  • Mutual funds1.16%
  • FII/FPI1.77%
  • Other DII0.02%
  • Public26.19%

Largest holders

NameCategoryShares %Shares
Pharmaceutical Business Group [India] LtdPromoter47.0200%51240000
Themis Medicare LimitedPromoter20.9000%22774847
Sachin Dinesh PatelPromoter2.2900%2497200
Quant Mutual Fund - Quant Manufacturing FundPublic1.1500%1254000
Ayushmat LtdPublic1.1200%1220000

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 70.86% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings decreased from 1.80% to 1.77% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings were unchanged at 1.16% in Jun 2026 qtr

All shareholding details →

Insider trading, SAST & pledges

All 0 insider trades, 2 SAST, 5 pledge events →

All insider and SAST disclosures →

Deals (Bulk & Block)

All 15 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
24 Apr 2026 NK SECURITIES RESEARCH PRIVATE LIMITED Bulk Buy 590,941 367.2200 NSE
24 Apr 2026 NK SECURITIES RESEARCH PRIVATE LIMITED Bulk Sell 590,941 367.4800 NSE
27 Dec 2023 MC JAIN INFOSERVICES PRIVATE LIMITED Bulk Buy 490,000 215.0000 BSE
27 Dec 2023 PHARMACEUTICAL BUSINESS GROUP I LTD Bulk Sell 3,000,000 215.3500 BSE
21 Apr 2017 MANJU PAREKH Bulk Buy 75,000 50.1900 BSE
21 Apr 2017 NEELKAMAL MOTILAL PAREKH Bulk Sell 75,000 50.1900 BSE
16 Mar 2015 PRABHAT PRABHAT Bulk Buy 22,316 39.3100 BSE
16 Mar 2015 PRABHAT PRABHAT Bulk Sell 93,773 38.2600 BSE
13 Mar 2015 PRABHAT PRABHAT Bulk Sell 6,721 37.9000 BSE
13 Mar 2015 PRABHAT PRABHAT Bulk Buy 78,178 36.6100 BSE

All bulk and block deals →

Dividends

Full dividend history →
Last 12 months ₹0.67 per share
Dividend yield 0.17%
Ex-dateSubjectPer share (₹)Record date
23 Sep 2026 Dividend - Re 0.67 Per Share 0.6700 23 Sep 2026
4 Sep 2025 Dividend - Re 0.67 Per Share 0.6700 5 Sep 2025

Board Meetings

View board meeting history →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
1 Sep 2026 Fund Raising —
7 Aug 2026 Financial Results/Fund Raising Yes
19 Jun 2026 Fund Raising —
19 Jun 2026 Board meeting Rescheduled —
6 Jun 2026 Fund Raising/Other business matters —

Corporate Announcements

All 151 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
1 Oct 2026 AGM/EGM Gujarat Themis Biosyn Ltd - 506879 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
1 Oct 2026 AGM/EGM Gujarat Themis Biosyn Ltd - 506879 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
1 Oct 2026 Shareholders meeting Scrutinizer's Report of 45th Annual General Meeting of the Company counter signed by the Chairman.
30 Sep 2026 AGM/EGM Gujarat Themis Biosyn Ltd - 506879 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
30 Sep 2026 AGM/EGM Gujarat Themis Biosyn Ltd - 506879 - Shareholder Meeting / Postal Ballot-Outcome of AGM
30 Sep 2026 Company Update Gujarat Themis Biosyn Ltd - 506879 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
30 Sep 2026 Shareholders meeting Gujarat Themis Biosyn Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results.
30 Sep 2026 Shareholders meeting Revised outcome of 45th Annual General Meeting of the Company due to typographical error.
30 Sep 2026 Amendment to AOA/MOA Gujarat Themis Biosyn Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.
30 Sep 2026 Shareholders meeting Gujarat Themis Biosyn Limited has informed the Exchange regarding Outcome of Annual General Meeting held on September 30, 2026

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Strong net profit margin (33.7%)
  • Comfortable interest coverage (14.9x)
  • Strong revenue growth YoY (22.1%)

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

  • PE above 35 (86.7) -- priced for continued strong execution

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Gujarat Themis Biosyn Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.